Compare LSE & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LSE | ECOR |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | China | United States |
| Employees | 173 | N/A |
| Industry | Metal Fabrications | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.3M | 81.0M |
| IPO Year | N/A | 2018 |
| Metric | LSE | ECOR |
|---|---|---|
| Price | $4.49 | $7.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 9.2K | ★ 95.7K |
| Earning Date | 01-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $32,032,000.00 |
| Revenue This Year | N/A | $33.60 |
| Revenue Next Year | N/A | $30.40 |
| P/E Ratio | $61.76 | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $3.20 | $4.16 |
| 52 Week High | $6.98 | $10.50 |
| Indicator | LSE | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 53.76 | 45.58 |
| Support Level | $3.94 | $4.75 |
| Resistance Level | $5.00 | $8.26 |
| Average True Range (ATR) | 0.39 | 0.93 |
| MACD | 0.08 | -0.11 |
| Stochastic Oscillator | 57.94 | 34.85 |
Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment, oil and gas engineering technical services, new energy production and operation, and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment, which supplies various equipment, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.